跳至主要内容
临床试验/NCT02910791
NCT02910791Unknown不适用

The Role of Bacterial Toxins in Human Skin Disease

National Jewish Health1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年2月20日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
To determine the molecular mechanisms by which cytokines in atopic dermatitis skin alters differentiation of skin keratinocytes

研究概览

简要总结

Atopic dermatitis and psoriasis are two skin diseases often associated with bacterial infections and inflammation. Studies indicate that skin cells from these patients may have some changes that make these patients more susceptible to bacterial infections. Inflammatory environment may have an effect on the function of skin cells.

The purpose of this study is to learn more about skin cells (keratinocytes and fibroblasts) and how they regulate skin barrier function. To study this we need to establish skin cells that can be grown in the laboratory. We will use small skin biopsies from patients with atopic dermatitis, psoriasis and healthy people as a source of these cells. Since these skin cells have a limited lifetime when grown in laboratory as part of the project we would like to modify them, which allows them to grow for long time in the research laboratory. Some of the collected skin biopsies and isolated skin cells will be used to examine what gene products they make.

详细描述

Visit 1 (if needed). Study subjects will be asked to read and sign the informed consent. At that time the study inclusion and exclusion criteria for the study will be reviewed. Subject will be given instructions to stop taking certain medications for 7 days prior to the next study visit. Alternatively, if Visit 1 will be done over the phone, subjects may be contacted via phone using a phone script to provide instructions for stopping these medications. In this case, the informed consent will be obtained by the subject at visit 2 prior to any study procedures being done.

If the subject takes occasional Aspirin (not taken daily), it will need to be withheld for seven days prior to visit 2.

If the subject takes oral antihistamines, it will need to be withheld for seven days prior to the subject's first appointment.

If the subject takes oral antibiotics, inform the subject the appointment can be scheduled seven days after their last dose of antibiotic has been taken.

If the subject takes topical medications including (but not restricted to), cyclosporine, Elidel, Protopic, topical corticosteroids and topical antibiotics, it will need to be withheld seven days prior to the subject's first appointment.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • If subjects takes occasional Aspirin (not taken daily), it will need to be withheld for seven days prior to Visit
  • If subjects takes oral antihistamines, it will need to be withheld for seven days prior to the subject's first appointment
  • If subjects takes topical medications including (but not restricted to), cyclosporine, Elidel, Protopic, topical corticosteroids and topical antibiotics, it will need to withheld seven days prior to the subject's first appointment.

排除标准

  • Women can not be pregnant or become pregnant during the study
  • Oral corticosteroids:
  • Any systemic immunosuppressive or immunomodulatory medication in the last 28 days.
  • Patients who have received immunotherapy in the past year.
  • Patients using anxiolytics or antidepressants
  • Antiviral therapies
  • Anticoagulants
  • Allergic to lidocaine
  • Daily Aspirin use

结局指标

主要结局

To determine the molecular mechanisms by which cytokines in atopic dermatitis skin alters differentiation of skin keratinocytes

时间窗: one year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Donald Leung, MD, PhD

Principal Investigator

National Jewish Health

研究点 (1)

Loading locations...

相似试验